Encap Drug Delivery has won a contract manufacturing deal for a European licensed liquid-filled capsule product after the owner parted from its current CMO.
The resignation of CEO Axel Muller was a mutual decision and not linked to delayed efforts to win European approval for the asthma drug Flutiform says delivery tech firm SkyePharma.
DSM Pharmaceutical Products (DPP) will sell APIs made by Indian manufacturer Indoco Remedies in a new agreement that fits with its global expansion plan.
BASF has hiked its prices for ethanolamines just days after asking the European Commission to review measures designed to stop US exporters selling the compound to manufacturers in Europe at less than cost.
in-PharmaTechnologist presents its round-up of the latest manufacturing headlines including new facilities for Aptar and Granules, and some good news for Swiss Novartis workers.
A new discovery platform for RNA delivery vehicles could mean 20 per cent more efficiency for guiding nanoparticles into cancer cells, say researchers.
Ashland says it will ramp up production of the tablet disintegrant and dissolution aid polyvinylpyrrolidone (PVPP) to meet growing drug industry demand.
Amarin plans to add a fourth API maker to its supply chain as it prepares for a potential launch of its triglyceride lowering therapy, AMR101, in the US in 2012.
Drug delivery tech firm SkyePharma has started reviewing operations at its facility in Muttenz, Switzerland in a move that could results in significant job cuts.
Chinese companies exporting drugs in bulk will come under the microscope next month when the Indian government sends a team of officials to inspect manufacturing plants.
Rousselot says its acquisition of Eastman Kodak’s Gel Corporation will boost its gelatine production capacity and help it meet soaring drug industry demand.
It’s been a busy year for API (active pharmaceutical ingredient) manufacturers with new facilities, cost pressures and regulatory developments all hitting the headlines.And it seems recent developments in HPAPIs (high potency APIs) have caused a stir...
China will keep its position as a leading API and intermediates supplier thanks to recovering global demand and the growth of the generic sector say market analysts.
BASF has raised its prices for three ethanolamines (EOA), key intermediates in the production of a wide range of active pharmaceutical ingredients (API).
